NCT03939754 is a clinical trial of Dedalo project in Lifestyle Risk Reduction, sponsored by Università degli Studi del Piemonte Orientale Amedeo Avogadro.

Who is sponsoring NCT03939754?

NCT03939754 is sponsored by Università degli Studi del Piemonte Orientale Amedeo Avogadro.

What drugs are being tested in NCT03939754?

Interventions in NCT03939754: Dedalo project.

What condition does NCT03939754 study?

NCT03939754 studies Lifestyle Risk Reduction.

Is NCT03939754 still recruiting?

NCT03939754 is currently status unknown. Last updated 7 May 2019.

Last reviewed 2019-05-07 · How we verify

NCT03939754

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dedalo Study Protocol: the Evaluation of a Community-level Multicomponent Lifestyle Intervention Effectiveness

Status unknown Last updated 7 May 2019

What this trial tests

trial testing Dedalo project in Lifestyle Risk Reduction in 428 participants. Status unknown.

Timeline

16 October 2018

Primary endpoint
30 May 2019

30 May 2020

Quick facts

Lead sponsor	Università degli Studi del Piemonte Orientale Amedeo Avogadro
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	428
Start date	16 October 2018
Primary completion	30 May 2019
Estimated completion	30 May 2020
Sites	1 location across Italy

Drugs / interventions tested

Dedalo project

Conditions studied

Lifestyle Risk Reduction — all drugs for Lifestyle Risk Reduction →

Sponsor

Università degli Studi del Piemonte Orientale Amedeo Avogadro

Who can join

Adults 40 to 75, any sex, with Lifestyle Risk Reduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The reduction of non-transmissible diseases (NCDs) is a community health priority and many NCDs are lifestyle related. In order to promote healthy lifestyle in Vercelli, the Local Health Authority (ASL) and the municipality of Vercelli and the University of Novara have realized the Dedalo project: a multicomponent community intervention. In Italy, few are the study evaluating the effectiveness of the multicomponent community intervention. Thus, aim of the study is to evaluate the effectiveness of Dedalo project in promoting lifestyle healthier change in the adult lifestyle general population in Vercelli.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Dedalo Project, a Community-based Prevention Program for the Promotion of Healthy Behaviors in Adult Population: Model Description and Target Population Assessment.
Bortoluzzi S, Coppo A, Alessi D, Parovina S, et al · · 2022 · cited 1× · PMID 35834152 · DOI 10.1007/s10935-022-00693-0

Verify or expand the search:

Other recruiting trials for Lifestyle Risk Reduction

Currently open trials in the same condition.

NCT07424443 — Pilot Study of a Brain Health Program in Senior Centers · NA · recruiting
NCT06822387 — Health Without Barriers/Salud Sin Barreras- Northern Colorado · NA · recruiting
NCT06424847 — Effects of a Lifestyle and Sleep Intervention in Non-exercising Adults · NA · recruiting
NCT06420817 — Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians · NA · active not recruiting
NCT04932928 — Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients · NA · recruiting

Other Università degli Studi del Piemonte Orientale Amedeo Avogadro trials

Trials by the same sponsor.

NCT07471581 — Patient Satisfaction Study at AOU Maggiore Della Carità (SCORE) · not yet recruiting
NCT07424209 — Hypnotic Communication in Cardiology: A Randomized Controlled Trial · NA · recruiting
NCT06260202 — Nutrition Under Noninvasive Ventilation · completed
NCT05630157 — Evaluation of Effectiveness of the Unplugged Program on Gambling Among Adolescents (GAPUnplugged) · NA · unknown
NCT04412655 — Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03939754 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Università degli Studi del Piemonte Orientale Amedeo Avogadro
Last refreshed: 7 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03939754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing